Therapeutic Advances in Infectious Disease

eISSN: 2049-937XpISSN: 2049-9361
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
1.5
SJR
Q4Infectious Diseases
SNIP
0.8

Journal Specifications

Overview
  • Publisher
    SAGE PUBLICATIONS LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    USD 1500
  • Publication Time
    9
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

check-iconMeets Top Publisher Standards: Essential for leading journals like Elsevier.
check-iconEnhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
check-iconTailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn morethumb-icon 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Hepatitis B
Hepatitis B virus
Hemorrhagic cystitis
Clostridium difficile
Microbial drug resistance
Cryptococcosis
BK virus
Methicillin-resistant Staphylococcus aureus
Intensive care unit
Entecavir
Health professionals
Confidence interval
Climate change
Risk of infection
Solid organ
Human herpesvirus
Severe acute respiratory syndrome coronavirus
Antimicrobial stewardship
Pulmonary cryptococcosis
Daptomycin

Year-wise Publication

FAQs

Since when has Therapeutic Advances in Infectious Disease been publishing? Faqs

The Therapeutic Advances in Infectious Disease has been publishing since 2013 till date.

How frequently is the Therapeutic Advances in Infectious Disease published? Faqs

Therapeutic Advances in Infectious Disease is published Continuous publication.

Who is the publisher of Therapeutic Advances in Infectious Disease? Faqs

The publisher of Therapeutic Advances in Infectious Disease is SAGE PUBLICATIONS LTD.

How can I view the journal metrics of Therapeutic Advances in Infectious Disease on editage? Faqs

For the Therapeutic Advances in Infectious Disease metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Therapeutic Advances in Infectious Disease? Faqs

The eISSN number is 2049-937X and pISSN number is 2049-9361 for Therapeutic Advances in Infectious Disease.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Hepatitis B, Hepatitis B virus, Hemorrhagic cystitis, Clostridium difficile, Microbial drug resistance, Cryptococcosis, BK virus, Methicillin-resistant Staphylococcus aureus, Intensive care unit, Entecavir, Health professionals, Confidence interval, Climate change, Risk of infection, Solid organ, Human herpesvirus, Severe acute respiratory syndrome coronavirus, Antimicrobial stewardship, Pulmonary cryptococcosis, Daptomycin.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.